Kaplan Fox Investigates Alignment Healthcare Accounting Practices
Kaplan Fox is investigating Alignment Healthcare for securities law violations, with new details confirming that systematic misclassification of operating expenses inflated Adjusted EBITDA. This accounting irregularity, exposed by a whistleblower complaint, led to a sharp 16.7% decline in the company's share price on July 8, 2026.
According to a new filing via GN stocks/nasdaq, the Kaplan Fox investigation specifically targets allegations that millions in operating expenses were systematically reclassified as capital expenditures to artificially boost Adjusted EBITDA. This alleged manipulation of key non-GAAP metrics reportedly triggered a 16.7% drop in the stock price back in July.
Source: GN stocks/nasdaqNew details confirm that systematic accounting irregularities inflated Alignment Healthcare's performance metrics, a misreporting scheme that caused a sharp drop in the company's share price.
Source: GN stocks/nasdaq
